42. Luban NL. Management of anemia in the newborn. Early Hum
44. Rabe H, Reynolds G, Diaz-Rossello J. A systematic review and
meta-analysis of a brief delay in clamping the umbilical cord of
preterm infants. Neonatology. 2008;93:138.
46. Eichler H, Schaible T, Richter E, et al. Cord blood as a source of
autologous RBCs for transfusion to preterm infants. Transfusion.
47. Nichols WG, Price TH, Gooley T, et al. Transfusion-transmitted
cytomegalovirus infection after receipt of leukoreduced blood
products. Blood. 2003;101:4195.
48. Fiebig EH, Busch MP. Infectious disease screening. In: Roback
JD, eds. Technical Manual of the American Association of Blood
Banks. 16th ed. Bethesda, MD: American Association of Blood
rates of detection of recently infected donors. Transfusion. 2005;
50. Busch MP, Kleinman SH, Nemo GJ. Current and emerging
infectious risks of blood transfusions. JAMA. 2003;289:959.
51. Dodd RY. Current risk for transfusion transmitted infections. Curr
52. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered
leukocyte-reduced and cytomegalovirus (CMV) seronegative
blood products for the prevention of transfusion-associated CMV
infection after marrow transplant. Blood. 1995;86:3598.
53. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial
contamination in apheresis platelet products: American Red
Cross experience, 2004. Transfusion. 2005;45:1845.
54. Ludlam CA, Turner ML. Managing the risk of transmission of
variant Creutzfeldt Jakob disease by blood products. Br J Haematol.
55. Yang X, Ahmed S, Chandrasekaran V. Transfusion-related acute
lung injury resulting from designated blood transfusion between
No comments:
Post a Comment